Most antibiotics used in human medicine originate from natural products derived from bacteria and other microbes. Novel microorganisms are therefore a promising source of new active compounds - also for the treatment of...
A team led by Prof. Achim Hoerauf, University Hospital Bonn (UKB), in cooperation with the University of Bonn and the Helmholtz Centre for Infection Research (HZI), is developing the antibiotic corallopyronin A (CorA)...
Lyme disease is the most common disease transmitted by tick bites in Germany. Whether a particular genetic predisposition plays a role in the development of the disease and which immunological processes in the body are...
Dr Katarina Barley, Member of the European Parliament, visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig on Tuesday, 30 April 2024. She was accompanied by Braunschweig's Mayor Dr Thorsten...
Today, around 70 students from years 5 to 9 visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig to get an idea of what it is like to work in a modern research facility. They got a taste of the...
The antimicrobial potential of CRISPR-Cas systems is promising, yet how to best design or implement CRISPR nucleases remains poorly understood. An international team led by the Helmholtz Institute for RNA-based...
The so-called B cells are part of the immune system's memory. Their memories of previous infections or vaccinations provide the template for antibodies that have a protective effect the next time they come into contact...
Scientists at the Helmholtz Centre for Infection Research (HZI) rely on working with laboratory animals to research infectious diseases in more detail and to understand the complex interactions between pathogens and...
Leukemia is the most common cancer in children. Cancer treatment severely weakens the children's immune system and they can easily develop opportunistic infections. One of the most common causes of such complications is...
